2026-01-20 | Company
Niklas Lindgren new Vice President of Quality at Sever Pharma Solutions
Sever Pharma Solutions is pleased to announce the appointment of Niklas Lindgren as the company’s new Vice President of Quality, effective January 19, 2026.
2026-01-20 | Company
Sever Pharma Solutions is pleased to announce the appointment of Niklas Lindgren as the company’s new Vice President of Quality, effective January 19, 2026.
2025-11-26 | Company
We are pleased to announce the appointment of Linda Rebert as its new VP Operations, effective December 1, 2025.
2025-11-12 | Company
We are proud to celebrate our 50th anniversary this year. The milestone marks five decades of innovation, expertise, and partnership in pharmaceutical development and manufacturing.
2025-09-01 | Company
We are pleased to announce the appointment of Malin Wendt as the new Supply Chain Management Director, effective September 1st, 2025.
2025-08-19 | Company
Sever Pharma Solutions is pleased to announce the publication of its Sustainability Report 2024, highlighting our ongoing commitment to responsible business practices and sustainable growth.
2025-08-14 | Company
Sever Pharma Solutions has made an expanded agreement with Silo Pharma, Inc. (Nasdaq: SILO).
2025-07-02 | Company
We are pleased to announce the appointment of Fredrik Hultenius as new Chief Executive Officer, effective July 1st, 2025.
2025-06-30 | Company
We’re delighted to share insights from Tony Listro, VP and Site Head of Sever Pharma Solution following a great interview at BIO2025.
2025-06-17 | Company
Capable to handle high-potent and cytotoxic injectable drugs at its Malmö facility.
2025-04-23 | Company
In 2024, our Putnam site fully commissioned and qualified two new High Potent API processing suites.